INSTAND 192 Antiepileptika
02 Exam
,Multiple-choice questions
Question 1
Which option correctly fills the blank in this technical statement?
Methodological Scope and Clinical Applications — Quality ____ for personalized dosage optimization in
neurology and psychiatry
A. treatments
B. toxicology
C. Methodologies
D. assurance
Correct Answer: D
Full Explanation: Methodological Scope and Clinical Applications: Quality assurance for personalized
dosage optimization in neurology and psychiatry. The required expression is “assurance”; it completes the
specific association described, rather than substituting a different concept.
Question 2
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
Sample Matrix and Characteristics: Carbamazepin-epoxid ([potential toxicity])
A. Anticonvulsants / Antiepileptic Drugs 02
B. potential toxicity
C. Carbamazepine-10,11-epoxide
D. Test Components10-OH-Carbazepin
Correct Answer: C
Full Explanation: Sample Matrix and Characteristics: Carbamazepin-epoxid
(Carbamazepine-10,11-epoxide). The required expression is “Carbamazepine-10,11-epoxide”; it completes
the specific association described, rather than substituting a different concept.
Question 3
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
Core Analytical [toxicity] and Test Components10-OH-Carbazepin (10-Hydroxycarbazepine / Licarbazepine)
A. Parameters
B. adverse
C. metabolite
D. toxicity
Correct Answer: A
Full Explanation: Sample Matrix and Characteristics: Core Analytical Parameters and Test
Components10-OH-Carbazepin (10-Hydroxycarbazepine / Licarbazepine). The required expression is
“Parameters”; it completes the specific association described, rather than substituting a different concept.
Record 3826 2
,Multiple-choice questions
Question 4
Which term correctly completes the following description?
Target Analytical Methodologies: High-performance liquid chromatography (HPLC), liquid
chromatography-tandem mass spectrometry (____), and specific immunoassays utilized in clinical toxicology
and therapeutic drug monitoring laboratories.
A. clearance
B. Prevention
C. LC-MS/MS
D. rates
Correct Answer: C
Full Explanation: Methodological Scope and Clinical Applications: Target Analytical Methodologies:
High-performance liquid chromatography (HPLC), liquid chromatography-tandem mass spectrometry
(LC-MS/MS), and specific immunoassays utilized in clinical toxicology and therapeutic drug monitoring
laboratories. The required expression is “LC-MS/MS”; it completes the specific association described, rather
than substituting a different concept.
Question 5
Which choice restores the intended meaning of the following description?
Regulatory Framework: Mandatory proficiency testing according to the Guidelines of the German Medical
____ (Rili-BÄK)
A. Association
B. optimization
C. accumulation
D. Qualitätssicherung
Correct Answer: A
Full Explanation: General Program Specifications: Regulatory Framework: Mandatory proficiency testing
according to the Guidelines of the German Medical Association (Rili-BÄK). The required expression is
“Association”; it completes the specific association described, rather than substituting a different concept.
Question 6
Which value or quantitative expression completes this description?
Sample Matrix and Characteristics — Sample Volume & Quantity: 2 samples, ____
A. 6 ml each per survey round
B. 4 ml each per survey round
C. 2 ml each per survey round
D. 3 ml each per survey round
Correct Answer: D
Full Explanation: Sample Matrix and Characteristics: Sample Volume & Quantity: 2 samples, 3 ml each per
survey round. The required expression is “3 ml each per survey round”; it completes the specific association
described, rather than substituting a different concept.
Record 3826 3
, Multiple-choice questions
Question 7
Which choice supplies the missing concept in this application?
Sample Matrix and Characteristics — ____ analysis for therapeutic drug monitoring (TDM) and efficacy
assessment
A. Lyophilized human serum
B. Serum concentration
C. refractory seizure
D. German Medical Association
Correct Answer: B
Full Explanation: Sample Matrix and Characteristics: Serum concentration analysis for therapeutic drug
monitoring (TDM) and efficacy assessment. The required expression is “Serum concentration”; it completes
the specific association described, rather than substituting a different concept.
Question 8
Which choice supplies the missing concept in this description?
Methodological Scope and Clinical Applications — Prevention of drug accumulation, metabolic toxicity, and
____ failure due to altered clearance rates
A. laboratories
B. therapeutic
C. Antiepileptic
D. toxicology
Correct Answer: B
Full Explanation: Methodological Scope and Clinical Applications: Prevention of drug accumulation,
metabolic toxicity, and therapeutic failure due to altered clearance rates. The required expression is
“therapeutic”; it completes the specific association described, rather than substituting a different concept.
Question 9
Identify the missing term that completes the stated relationship.
Scientific Leadership / Coordination: Prof. Dr. med. Werner ____, Dr. rer. nat. Heike Schneider
A. Rili-BÄK
B. Steimer
C. Laboratorien
D. Gesellschaft
Correct Answer: B
Full Explanation: General Program Specifications: Scientific Leadership / Coordination: Prof. Dr. med.
Werner Steimer, Dr. rer. nat. Heike Schneider. The required expression is “Steimer”; it completes the specific
association described, rather than substituting a different concept.
Record 3826 4
02 Exam
,Multiple-choice questions
Question 1
Which option correctly fills the blank in this technical statement?
Methodological Scope and Clinical Applications — Quality ____ for personalized dosage optimization in
neurology and psychiatry
A. treatments
B. toxicology
C. Methodologies
D. assurance
Correct Answer: D
Full Explanation: Methodological Scope and Clinical Applications: Quality assurance for personalized
dosage optimization in neurology and psychiatry. The required expression is “assurance”; it completes the
specific association described, rather than substituting a different concept.
Question 2
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
Sample Matrix and Characteristics: Carbamazepin-epoxid ([potential toxicity])
A. Anticonvulsants / Antiepileptic Drugs 02
B. potential toxicity
C. Carbamazepine-10,11-epoxide
D. Test Components10-OH-Carbazepin
Correct Answer: C
Full Explanation: Sample Matrix and Characteristics: Carbamazepin-epoxid
(Carbamazepine-10,11-epoxide). The required expression is “Carbamazepine-10,11-epoxide”; it completes
the specific association described, rather than substituting a different concept.
Question 3
A proposed description contains an incorrect bracketed expression. Which replacement makes the
description accurate?
Core Analytical [toxicity] and Test Components10-OH-Carbazepin (10-Hydroxycarbazepine / Licarbazepine)
A. Parameters
B. adverse
C. metabolite
D. toxicity
Correct Answer: A
Full Explanation: Sample Matrix and Characteristics: Core Analytical Parameters and Test
Components10-OH-Carbazepin (10-Hydroxycarbazepine / Licarbazepine). The required expression is
“Parameters”; it completes the specific association described, rather than substituting a different concept.
Record 3826 2
,Multiple-choice questions
Question 4
Which term correctly completes the following description?
Target Analytical Methodologies: High-performance liquid chromatography (HPLC), liquid
chromatography-tandem mass spectrometry (____), and specific immunoassays utilized in clinical toxicology
and therapeutic drug monitoring laboratories.
A. clearance
B. Prevention
C. LC-MS/MS
D. rates
Correct Answer: C
Full Explanation: Methodological Scope and Clinical Applications: Target Analytical Methodologies:
High-performance liquid chromatography (HPLC), liquid chromatography-tandem mass spectrometry
(LC-MS/MS), and specific immunoassays utilized in clinical toxicology and therapeutic drug monitoring
laboratories. The required expression is “LC-MS/MS”; it completes the specific association described, rather
than substituting a different concept.
Question 5
Which choice restores the intended meaning of the following description?
Regulatory Framework: Mandatory proficiency testing according to the Guidelines of the German Medical
____ (Rili-BÄK)
A. Association
B. optimization
C. accumulation
D. Qualitätssicherung
Correct Answer: A
Full Explanation: General Program Specifications: Regulatory Framework: Mandatory proficiency testing
according to the Guidelines of the German Medical Association (Rili-BÄK). The required expression is
“Association”; it completes the specific association described, rather than substituting a different concept.
Question 6
Which value or quantitative expression completes this description?
Sample Matrix and Characteristics — Sample Volume & Quantity: 2 samples, ____
A. 6 ml each per survey round
B. 4 ml each per survey round
C. 2 ml each per survey round
D. 3 ml each per survey round
Correct Answer: D
Full Explanation: Sample Matrix and Characteristics: Sample Volume & Quantity: 2 samples, 3 ml each per
survey round. The required expression is “3 ml each per survey round”; it completes the specific association
described, rather than substituting a different concept.
Record 3826 3
, Multiple-choice questions
Question 7
Which choice supplies the missing concept in this application?
Sample Matrix and Characteristics — ____ analysis for therapeutic drug monitoring (TDM) and efficacy
assessment
A. Lyophilized human serum
B. Serum concentration
C. refractory seizure
D. German Medical Association
Correct Answer: B
Full Explanation: Sample Matrix and Characteristics: Serum concentration analysis for therapeutic drug
monitoring (TDM) and efficacy assessment. The required expression is “Serum concentration”; it completes
the specific association described, rather than substituting a different concept.
Question 8
Which choice supplies the missing concept in this description?
Methodological Scope and Clinical Applications — Prevention of drug accumulation, metabolic toxicity, and
____ failure due to altered clearance rates
A. laboratories
B. therapeutic
C. Antiepileptic
D. toxicology
Correct Answer: B
Full Explanation: Methodological Scope and Clinical Applications: Prevention of drug accumulation,
metabolic toxicity, and therapeutic failure due to altered clearance rates. The required expression is
“therapeutic”; it completes the specific association described, rather than substituting a different concept.
Question 9
Identify the missing term that completes the stated relationship.
Scientific Leadership / Coordination: Prof. Dr. med. Werner ____, Dr. rer. nat. Heike Schneider
A. Rili-BÄK
B. Steimer
C. Laboratorien
D. Gesellschaft
Correct Answer: B
Full Explanation: General Program Specifications: Scientific Leadership / Coordination: Prof. Dr. med.
Werner Steimer, Dr. rer. nat. Heike Schneider. The required expression is “Steimer”; it completes the specific
association described, rather than substituting a different concept.
Record 3826 4
